MOH — authorised 15 October 2014
- Marketing authorisation holder: BOEHRINGER INGELHEIM
- Status: likely_approved
🇮🇱 Ofev in Israel
MOH authorised Ofev on 15 October 2014
Marketing authorisations
MOH — authorised 2 April 2026
- Marketing authorisation holder: DEXCEL
- Status: likely_approved
Ofev in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Ofev approved in Israel?
Yes. MOH authorised it on 15 October 2014; MOH authorised it on 2 April 2026.
Who is the marketing authorisation holder for Ofev in Israel?
BOEHRINGER INGELHEIM holds the Israeli marketing authorisation.